Saudi Arabia

A core focus of the partnership is building stronger capabilities among eye care professionals, whereby the two organizations will develop and launch specialized training programs designed for doctors and healthcare practitioners working in ophthalmology.

As part of Aramex’s broader strategy, the hub consolidates a comprehensive suite of logistics services into one integrated operation.

This restructuring will eliminate the complexity of managing multiple international offices while concentrating resources and expertise in the Kingdom.

The SEEG procedure operates as a sophisticated mapping tool, allowing neurosurgeons to precisely identify the exact regions of the brain responsible for triggering seizures.

This advanced immunotherapy works by modifying a patient’s own immune cells to better identify and destroy cancer cells.

Saudi Arabia’s pharmaceutical market projects growth to USD15.6 billion by 2030, up from USD11.8 billion in 2024.

The facility will occupy a 23,250-square-meter site in Sudair Industrial City, a planned development located 93 miles northwest of Riyadh.

The Cardiovascular CoE brings together cardiology, cardiac surgery, and vascular medicine within a single coordinated program.

The standalone Eye Care Center occupies 750 square meters of space, delivering an impressive 83% increase in clinical capacity compared to the previous facility.

The award acknowledges Sanofi’s consistent efforts in creating sustainable employment opportunities for Saudi nationals while simultaneously building robust leadership capabilities across its regional operations.